In this week's Advocacy Update, NCPA reports on PAC fundraising, a move for CMS to finalize DIR guidance, TRICARE mail order requirements, and more!

This week's Advocacy Center Update includes information on TRICARE, Medicare Part D, FDA meetings, and clozapine.

This week's Advocacy Center update looks at John Boehner's retirement, TRICARE changes, the 2016 Part D landscape, and more!

Reminder: TRICARE Brand Name Rx Changes Coming Oct. 1: Please let your patients know this impacts select brand name maintenance drugs only!

Your weekly update on NCPA's legislative advocacy efforts is here!